Clinical trial
Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in…
NCT00317252 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00317252 |
|---|---|
| Title | Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization |
| Official title | Angiotensin Converting Enzyme Inhibitors and Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization "The CAPTAIN Trial" |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Failure |
| Intervention type | Drug |
| Interventions | Hold ACEI or ARB |
| Enrollment | 220 |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Apr 24, 2006 |
| Last update posted | Oct 22, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: